Paul Johnson, PhD, DABCC, MLS(ASCP), FAACC
RESEARCH PROGRAMS AND AFFILIATIONS
Concussion injury biomarkers, Clinical applications of laboratory statistics
ASSOCIATIONS / MEMBERSHIPS
Dr. Paul Johnson began his professional career in Chicago as a clinical laboratory scientist after completing a medical technology fellowship in the Department of Pathology at Newton-Wellesley Hospital. He earned a Ph.D. degree in Biochemistry & Molecular Biology from the University of Louisville Medical School, where he had studied molecular chaperones and transcription factor interactions in human neutrophils.
His clinical research focus at Upstate Medical University began with a study on the diagnostic utility of concussion injury biomarkers in human subjects with a goal of improving early diagnosis. Current research efforts are focused on applied statistics in laboratory medicine; most especially on the dynamics of human biological variation of laboratory test results with direct applications to clinical-decision making and validation of instrument testing platforms.
Dr. Johnson is board-certified in the field of clinical laboratory medicine by both the American Board of Clinical Chemistry and the American Society for Clinical Pathology. He currently teaches laboratory medicine courses with specialty focus areas of clinical biochemistry and statistics.
Johnson PR, Shahangian S, Astles JR. Managing biological variation data: modern approaches for study design and clinical application. Crit Rev Clin Lab Sci. 2021 Jun 15:1-20
Johnson PR. Setting Analytical Quality Goals with Biological Variation Data. AACC Pearls of Laboratory Medicine. 2019 Nov 15. Video link
LaRocca D, Barns S, Hicks SD, Brindle A, Williams J, Uhlig R, Johnson P, Neville C, Middleton FA. Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters. PLoS One. 2019 Jan 2;14(1):e0207785.
Johnson PR, Gwilt SC, Neville CG. Estimates of Within-Person Biological Variation and Reference Change Values of Serum S100B and NSE Proteins. Clin Chem. 2018 May;64(5):866-868. doi: 10.1373/clinchem.2017.285973. Epub 2018 Feb 26.
Kufel WD, Miller CD, Johnson PR, Reid K, Zahra JJ, Seabury RW. Y-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: Do current compatibility testing methodologies tell the whole story? Hosp Pharm 2017;52:132-7.
Neville C, Johnson PR, Baracks J, Rieger B. Exposure to injury in mixed-martial-arts is associated with evidence of concussion injury. Concussion Consensus Conference; Berlin, Germany. October, 2016. [abstract/poster]
Johnson PR, Neville CG. Evaluation of serum biomarker assays for mild traumatic brain injury in a cohort of mixed martial arts fighters. American Association for Clinical Chemistry (AACC), 68th Annual Scientific Meeting, Philadelphia, PA, August 2016. [abstract/poster]